000 | 01199 a2200361 4500 | ||
---|---|---|---|
005 | 20250513205244.0 | ||
264 | 0 | _c20000511 | |
008 | 200005s 0 0 eng d | ||
022 | _a0312-5963 | ||
024 | 7 |
_a10.2165/00003088-200038030-00002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTod, M | |
245 | 0 | 0 |
_aClinical pharmacokinetics and pharmacodynamics of isepamicin. _h[electronic resource] |
260 |
_bClinical pharmacokinetics _cMar 2000 |
||
300 |
_a205-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAging _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aGentamicins _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aInjections, Intramuscular |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aTissue Distribution |
700 | 1 | _aPadoin, C | |
700 | 1 | _aPetitjean, O | |
773 | 0 |
_tClinical pharmacokinetics _gvol. 38 _gno. 3 _gp. 205-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/00003088-200038030-00002 _zAvailable from publisher's website |
999 |
_c10702894 _d10702894 |